THE PROGRAM

08:00

Registration and Morning Refreshments

09:00

Welcome Address

09:15

Keynote Lecture

Gidi Rechavi, Sheba Cancer Research Center, Israel

Epitranscriptomics is entering the therapeutic arena​ ​

10:00

Shulamit Levenberg, Technion, Israel

Engineered skeletal muscle constructs overexpressing GLUT4 for type 2 diabetes treatment

10:20

Rotem Karni, The Hebrew University of Jerusalem, Israel

Modulating RNA processing for therapy

10:40

Batsheva Kerem, The Hebrew University of Jerusalem, Israel

Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach

11:00

Coffee Break

11:30

Eyal Banin, The Hebrew University of Jerusalem / Hadassah Medical Center, Israel

Gene Augmentation Therapy for Achromatopsia Caused by Mutations in the CNGA3 Gene: The Journey from Molecular Genetics to Clinical Application

11:50

Orit Shefi, Bar-Ilan University, Israel

Neuro-engineering tools for nerve regeneration ​

12:10

Lior Gepstein, Technion, Israel

Gene and cell therapy approaches for cardiac disorders​

12:30

Edward Wong, GenScript

Cancer Immunotherapy: The next generation of cancer treatment

12:50

Short Talk: Amnon Peled, Hadassah Hebrew University Hospital, Israel

Targeting cancer using super activated killer cells (SAK)

12:56

Short Talk: Liron Elkouby, NOGA Therapeutics, Israel

Development of safe and effective lentiviral vector for gene therapy of X-linked Agammaglobulinemia (XLA) utilizing endogenous Bruton's Tyrosine Kinase (BTK) regulation

13:02

Short Talk: Daniel Allen, Bar-Ilan University, Israel

High-throughput imaging of CRISPR- and rAAV-induced DNA damage response in human Hematopoietic Stem and Progenitor cells 

13:08

Short Talk: Ignacio Mastandrea, Tel Aviv University, Israel

Boosting CAR T Cell efficacy by modulation of the tumor microenvironment in Glioblastoma

13:14

Short Talk: Alessio D. Nahmad, Tel Aviv University, Israel

Frequent CRISPR-Cas9 induced Aneuploidy in primary human T Cells

13:20

Short Talk: Yaara Ohayon, Sheba Medical Center, Israel 

Establishment of a national cost-effective cGMP manufacturing infrastructure to support Israel novel gene therapies

13:25

Yaron Ramati, Gilboa, Israel

Development and regulation of advanced therapies​

13:30

Lunch and Poster Session

15:00

Karen B. Avraham, Tel Aviv University, Israel

Rescuing hearing with AAV: Stories from Syne4

15:20

Eric Shifrut, Tel Aviv University, Israel

CRISPR discovery platforms for engineered T cell therapies

15:40

Marcelo Erlich, Tel Aviv University, Israel

Oncolytic virotherapy: exploiting cancer-induced modifications to cell autonomous immunity

16:00

Adi Barzel, Tel Aviv Univervisty, Israel

In vivo B cell engineering

16:20

Dan Peer, Tel-Aviv University, Israel

The RNA revolution: from Gene Silencing to Gene Editing

16:40

Closing Remarks

17:00

Panel Discussion (Hybrid) - Location: Britannia Building, Room 014

Gene delivery technologies for therapeutic applications

Moderated by Professor Dan Peer

Panelists: 

Ronit Satchi-Fainaro, Tel Aviv University, Israel

Laura Sepp-Lorenzino, CSO, Intellia

James McArthur, CEO, Pepgen

Patrick Baumhof, VP, RNA formulation in Curevac

Pete Lutwyche, CEO & President, Genevant